Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(10.2%)
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.46%)
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Nikko Asset Management Americas, Inc.(4.94%)
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”)(4.94%),Nikko Asset Management Co., Ltd. (“NAM”)(4.94%)
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-ARK Investment Management LLC(7.66%)
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(9.0%)
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(6.10%)
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Federated Hermes, Inc.(17.63%),Voting Shares Irrevocable Trust(17.63%)等
Arcturus Therapeutics | 4:持股变动声明-首席财务官 SASSINE ANDY
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | 4:持股变动声明-首席法务官 Kurata Lance
Arcturus Therapeutics | 4:持股变动声明-高管 Kummerfeld Keith C
Arcturus Therapeutics | 4:持股变动声明-高管 Payne Joseph E
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(6.27%)
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | 4:持股变动声明-首席财务官 SASSINE ANDY
暂无数据